Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical‐Cellular) Screening System-Reference-Cited by-同舟云学术

Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical‐Cellular) Screening System

Published:2020-05-20 Issue:8 Volume:3 Page:2000037
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Adv. Therap.

Author:

Benitez‐Amaro Aleyda¹²,Pallara Chiara³,Nasarre Laura¹,Ferreira Ruben³,Gonzalo‐Calvo David¹²⁴,Prades Roger³,Tarragó Teresa³,Llorente‐Cortés Vicenta¹²⁴^ORCID

Affiliation:

1. Institute of Biomedical Research of Barcelona (IIBB)Spanish National Research Council (CSIC) Barcelona 08036 Spain

2. Group of Lipids and Cardiovascular PathologyBiomedical Research Institute Sant Pau (IIB Sant Pau)Hospital de la Santa Creu i Sant Pau Barcelona 08025 Spain

3. Iproteos S.LBarcelona Science Park (PCB) Barcelona 08028 Spain

4. CIBER enfermedades cardiovasculares (CIBERcv) Madrid 28029 Spain

Funder

Instituto de Salud Carlos III

Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya

Fundació la Marató de TV3

Ministerio de Ciencia, Innovación y Universidades

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry (medical),Genetics (clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link